REVOLVING LOAN	9 Months Ended
Sep. 30, 2026
Debt Disclosure [Abstract]
REVOLVING LOAN	REVOLVING LOAN On July 27, 2022, the Company entered into an Amended and Restated Credit Agreement (the "2022 Credit Agreement") with certain lenders in the form of a senior secured revolving credit facility. On July 24, 2026, the Company entered into Amendment No. 1 to the 2022 Credit Agreement (the "Credit Agreement Amendment"), which increased the aggregate revolving commitment amount from $550,000 to $650,000, extended the maturity date of the credit facility from July 27, 2027 to July 24, 2031, and made certain other amendments to the facility terms. The loans may be used for working capital, letters of credit, and other corporate purposes and may be drawn upon at the Company’s discretion. The Company used initial proceeds from the Credit Agreement Amendment to repay the outstanding balance of $152,000 due in July 2027 under the 2022 Credit Agreement. The amendment was accounted for as a modification of the existing debt arrangement. As of September 30, 2026 and December 31, 2025, the total balance outstanding under the revolving credit facility amounted to $124,000 and $164,000, respectively. There are no installment payments required on the revolving loans. The loans may be voluntarily prepaid in whole or in part without premium or penalty, and all outstanding amounts are due on the maturity date. Amounts outstanding under the revolving credit facility are subject to an interest rate equal to a fluctuating rate as defined by the Credit Agreement Amendment plus an applicable rate. The applicable rate is based upon the Company’s consolidated net leverage ratio, as defined in the Credit Agreement Amendment, and the interest rate was 4.90% at September 30, 2026. The Company is also required to pay a commitment fee on the unused portion of the revolving loan, which is based on the Company’s consolidated net leverage ratio as defined in the Credit Agreement Amendment and ranges from 0.150% to 0.225% (0.150% at September 30, 2026). The unused portion of the revolving loan amounted to $526,000 at September 30, 2026. The Company is also required to pay, as applicable, letter of credit fees, administrative agent fees, and other fees to the arrangers and lenders. Costs associated with the issuance of the revolving loans are capitalized and amortized on a straight-line basis over the term of the Credit Agreement Amendment, which is not materially different than the effective interest method. Capitalized costs net of accumulated amortization were $2,108 and $455 at September 30, 2026 and December 31, 2025, respectively, and are included in "Other non-current assets" on the condensed consolidated balance sheets. Amortization expense pertaining to these costs totaled $101 and $245 for the three and nine months ended September 30, 2026, respectively, and $72 and $216 for the three and nine months ended September 30, 2025, respectively, and are included in "Interest expense, net" in the accompanying condensed consolidated statements of earnings. The Credit Agreement Amendment contains quarterly covenants requiring the consolidated leverage ratio to be less than a certain maximum ratio and the consolidated interest coverage ratio to exceed a certain minimum ratio. At September 30, 2026, the Company was in compliance with these covenants. Indebtedness under the Company’s loan agreements is secured by assets of the Company.

On July 27, 2022, the Company entered into an Amended and Restated Credit Agreement (the "2022 Credit Agreement") with certain lenders in the form of a senior secured revolving credit facility. On July 24, 2026, the Company entered into Amendment No. 1 to the 2022 Credit Agreement (the "Credit Agreement Amendment"), which increased the aggregate revolving commitment amount from $550,000 to $650,000, extended the maturity date of the credit facility from July 27, 2027 to July 24, 2031, and made certain other amendments to the facility terms. The loans may be used for working capital, letters of credit, and other corporate purposes and may be drawn upon at the Company’s discretion. The Company used initial proceeds from the Credit Agreement Amendment to repay the outstanding balance of $152,000 due in July 2027 under the 2022 Credit Agreement. The amendment was accounted for as a modification of the existing debt arrangement.

As of September 30, 2026 and December 31, 2025, the total balance outstanding under the revolving credit facility amounted to $124,000 and $164,000, respectively. There are no installment payments required on the revolving loans. The loans may be voluntarily prepaid in whole or in part without premium or penalty, and all outstanding amounts are due on the maturity date. Amounts outstanding under the revolving credit facility are subject to an interest rate equal to a fluctuating rate as defined by the Credit Agreement Amendment plus an applicable rate. The applicable rate is based upon the Company’s consolidated net leverage ratio, as defined in the Credit Agreement Amendment, and the interest rate was 4.90% at September 30, 2026.

The Company is also required to pay a commitment fee on the unused portion of the revolving loan, which is based on the Company’s consolidated net leverage ratio as defined in the Credit Agreement Amendment and ranges from 0.150% to 0.225% (0.150% at September 30, 2026). The unused portion of the revolving loan amounted to $526,000 at September 30, 2026. The Company is also required to pay, as applicable, letter of credit fees, administrative agent fees, and other fees to the arrangers and lenders.

Costs associated with the issuance of the revolving loans are capitalized and amortized on a straight-line basis over the term of the Credit Agreement Amendment, which is not materially different than the effective interest method. Capitalized costs net of accumulated amortization were $2,108 and $455 at September 30, 2026 and December 31, 2025, respectively, and are included in "Other non-current assets" on the condensed consolidated balance sheets. Amortization expense pertaining to these costs totaled $101 and $245 for the three and nine months ended September 30, 2026, respectively, and $72 and $216 for the three and nine months ended September 30, 2025, respectively, and are included in "Interest expense, net" in the accompanying condensed consolidated statements of earnings.

The Credit Agreement Amendment contains quarterly covenants requiring the consolidated leverage ratio to be less than a certain maximum ratio and the consolidated interest coverage ratio to exceed a certain minimum ratio. At September 30, 2026, the Company was in compliance with these covenants. Indebtedness under the Company’s loan agreements is secured by assets of the Company.